A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
about
MDA-MB-468MDA-MB-231MCF-7HCC1937MDA-MB-435BT-20600MPEAU565BT-474BT-483BT-549CAMA-1HBL-100HCC1007HCC1143HCC1187HCC1428HCC1500HCC1569HCC1954HCC202HCC2157HCC2185HCC3153HCC38HCC70Hs 578TMCF-10AMCF-12AMCF-7/LY2MDA-MB-134-VIMDA-MB-157MDA-MB-175-VIIMDA-MB-361MDA-MB-415MDA-MB-436MDA-MB-453SUM1315MO2SUM149PTSUM159PT
P1343
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelLong chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancerTranscription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancerMethylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancerSuppression of breast tumor growth and metastasis by an engineered transcription factorThe ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneityA precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancersUse of data-biased random walks on graphs for the retrieval of context-specific networks from genomic dataPD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroAutocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivationProlactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent mannerPI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture.ZNF703 gene amplification at 8p12 specifies luminal B breast cancerCooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancerDual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancerAn EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancerErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancersMethylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancersNuclear translocation of beta-dystroglycan reveals a distinctive trafficking pattern of autoproteolyzed mucinsThe prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancerFAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cellsLysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cellsActivity of the kinesin spindle protein inhibitor ispinesib (SB-715992) in models of breast cancerTumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesThe transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progressionRegulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenIntegrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerEpithelial-mesenchymal transition in cancer: parallels between normal development and tumor progressionIL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cellsA sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genomeThe NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor genePrognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-betLatent bone metastasis in breast cancer tied to Src-dependent survival signalsCD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesCo-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesisMinimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsIn vitro comparative models for canine and human breast cancersThe Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and MetastasisCancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine
P2860
Q16880225-29C2C8F1-21CC-43FD-9B63-AFEDA8DFBB33Q17577870-DE99724F-3B21-4A04-8013-25C5D9D52915Q1881253-393E25A8-EA2C-4AC1-8281-821A0E076759Q28872477-2061EBBC-9204-470A-B539-1EA8D1291770Q50952937-EAC68CDD-1FC2-48A7-BF71-22B484396788Q52392673-BD5CA0D6-419E-4D07-8879-520605DD0ED1Q54604225-65782932-5F20-47F4-9F2A-27A09EE78B76Q54751885-1AAD32F4-F150-4D2A-BB60-D76F31720CBEQ54798460-E081DD87-60F5-4F4A-B7E9-58AF04DF3230Q54798468-4B38F5E2-4D92-462B-8E7E-0B18E566B6FBQ54798471-BE371FB1-2CB8-4FBE-9C3F-563EC02C1DA6Q54808432-F26905D5-0089-43BF-A72D-6069ADEC4678Q54881428-838DAB56-1F37-4529-8A14-6DAED3A87A8FQ54881517-546B97FB-CB87-4FE8-B46D-BA252B26EDDEQ54881530-D4A731D2-39BF-492E-A8CE-4F510F398672Q54881536-AB8EBBE0-8D7E-42B4-A336-3C0D7DEAFE03Q54881570-13B9D467-14D0-45D1-A8A7-EA714083A1CCQ54881583-1ADC2EE9-13C5-474C-9806-08D0642F504BQ54881587-7F3F56D6-E663-4D29-A8F0-79F9637951E8Q54881618-0370A57C-D2D9-4FF4-AFB8-346015870BC0Q54881628-10905CE0-0071-4D1B-A33E-C493FDC31E7BQ54881634-A979A1F8-88C5-4396-972B-8C8BEA37E99EQ54881636-4B7DAAC0-90ED-4266-9929-B806BBD43ED2Q54881686-D2ADE029-82E8-480C-872C-3D417C1C803CQ54881712-70FA0634-6C81-4234-9BDA-DA2614A62C0DQ54881772-E0E768C6-4F2A-4986-BE8D-416BF4B10689Q54895774-47C3102B-BAD5-4AB1-8662-C7C0EE51C497Q54904280-1247FBA2-B08C-4D59-8D09-16CB09663F84Q54904301-B334E3FF-DA2A-43E3-B06E-CEE620E3A6CEQ54904374-AE923270-155A-4304-8D70-9BC21122FCC7Q54904577-F1DC1096-AD24-4914-B3E0-D9BA6A136DD7Q54904578-6112DC22-C323-465F-8AC3-F0FCD1CCC100Q54904579-7D7FC530-BFD6-4446-9CBC-AECC9ACD17EDQ54904626-C98390EC-EF74-4D07-A10B-4ACB755E0E4EQ54904630-8005769F-C78E-4863-8A1F-536FAEA7D782Q54904639-558919D5-A6D1-497B-9F39-AD4F951D44D4Q54904642-1A6B2DCD-3CF8-456D-A66B-AC9D6E3DFB08Q54970827-6DD48C1D-D29B-4EA5-A43B-DA06802D87B9Q54970832-5054271A-CC2E-4E04-AD27-861133392453Q54970841-63B5DCBD-C2C8-403E-BC5A-232EBA6868A8
P1343
Q21090788-A1D97ABB-2707-4C3E-BA8D-34BB8BF86DF2Q21132473-0297EE35-037C-4EEC-A2E2-A6A60106564CQ21132487-ABA83F8A-04FC-4A94-811A-C5C432043001Q21134780-38B6B370-3F12-43EC-B303-AD5F63CA88EBQ21135222-3FB3D910-F3F3-463C-8AF3-56CDECCE74E7Q21136336-4866E005-4559-4A2C-B852-1CEE62DEA27AQ21145043-140DF9C2-A69D-4BEE-8630-7E0C54166BA7Q21145334-4C52A5ED-D92D-45DC-8711-311F3D8B92F3Q21195212-2C170CE8-A80B-48B2-AB87-392C9045CF8FQ21195230-EE0F6976-7F3E-479B-99C4-31A10A05B317Q21559661-7A40F0F2-E20A-4D9F-A748-988C9C62F1D2Q22000770-DB6449F4-973A-4FD9-9D88-D72089E0893AQ24293333-15AA09EE-A4F1-4CA2-A4D3-D6A160BFA698Q24295934-D25246A2-DD00-4483-955F-2259993E241EQ24297047-08018091-C861-4766-934F-A913A3FA82C4Q24297853-C8174CDD-9B6D-415A-BEFE-6C1D5536F699Q24303562-4FD8944E-75AE-449D-934D-8B96ADE3A7EDQ24309483-003F4EA3-9828-4CF5-9F01-51AF8A5E657FQ24309527-B91B25D6-2282-4F88-88C1-6BD7DCA38301Q24310299-A64F167A-EE1D-4CB2-A61D-3FA9AE5F9F97Q24313524-6D0D3A2F-B9E1-490E-B9EA-4AD601F7532BQ24329077-F923E187-3FF1-4ECE-BAB2-418AF2B00204Q24606012-EBBE617C-F905-4DF4-ADFB-1F2ABA71A2E6Q24615262-A95A3D00-365A-4F84-AFAA-87896C774716Q24630783-3F397447-C0F9-4814-8F6E-763D5A52C015Q24632821-64836D0C-5D8A-412B-9BB4-C7919354A05CQ24632895-FE5EE5BA-EFA0-4AC4-89BC-DAB31256655EQ24633201-10DDF347-2BAC-42F5-88C8-693116B7B33EQ24633875-DE71D58F-5341-4D7F-9322-CD92E12CCE1AQ24634798-3C18D696-C4F2-44B7-A1B1-97837C6A5B9DQ24644321-4C728CE2-0F41-4117-BC51-59E58C0457D2Q24645371-2A3D0263-A34D-4244-A482-B8989E59C62CQ24645449-DCCFD35D-D0F6-4045-8ACE-2DC49364437BQ24648828-9F5208CB-4D39-47B0-8D96-CEB6539BF754Q24654220-F66E0C68-DA36-45FF-BCDF-E254A97A411AQ24655172-40317C3B-2261-4128-A2DB-2F23A9C738BCQ26748850-6095DCB9-AB5C-4D34-A585-5342B5BF8E85Q26752714-E506C5DF-84CF-4D4B-877E-6D3DA7E7ABCFQ26782727-4E4B360E-79BB-4621-B374-F531E159C0CBQ26800337-78088595-149F-4A79-9F50-17AE7B501CEE
P2860
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
A collection of breast cancer ...... nally distinct cancer subtypes
@ast
A collection of breast cancer ...... nally distinct cancer subtypes
@en
A collection of breast cancer ...... nally distinct cancer subtypes
@nl
type
label
A collection of breast cancer ...... nally distinct cancer subtypes
@ast
A collection of breast cancer ...... nally distinct cancer subtypes
@en
A collection of breast cancer ...... nally distinct cancer subtypes
@nl
prefLabel
A collection of breast cancer ...... nally distinct cancer subtypes
@ast
A collection of breast cancer ...... nally distinct cancer subtypes
@en
A collection of breast cancer ...... nally distinct cancer subtypes
@nl
P2093
P2860
P4510
P3181
P1433
P1476
A collection of breast cancer ...... nally distinct cancer subtypes
@en
P2093
Adi Gazdar
Anna Lapuk
Daniel Pinkel
Donna G Albertson
Frances Tong
Frank McCormick
Frederic M Waldman
Frederick L Baehner
Jackie L Stilwell
Jane Fridlyand
P2860
P304
P3181
P356
10.1016/J.CCR.2006.10.008
P407
P50
P577
2006-12-01T00:00:00Z